Share of U.S. adults with GLP-1 prescriptions

Among those who submitted health insurance claims; Annually, 2019-2024

A bar chart showing the share of U.S. adults with GLP-1 prescriptions. The share rose from 0.87% in 2019 to 4.03% in 2024. Ozempic is the most commonly prescribed, making up about half of GLP-1 prescriptions in 2024.

(Please use a modern browser to see the interactive version of this visualization)